HHealth Read More Cheap, Copycat Ozempic Was Supposed to Go Away. It’s Still Everywhere.September 21, 2025 The copycat weight-loss drugs party was supposed to be over, but it’s still raging on. Because of shortages…
MMedication Read More Wegovy And Zepbound Cost Effective But They Could Break Drug BudgetsSeptember 11, 2025 The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
MMedication Read More Pricing group says weight-loss drugs becoming more cost-effectiveSeptember 9, 2025 By Deena Beasley (Reuters) -An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become…
MMedication Read More GLP-1 drugs and vision loss: How significant are the risks? – Medical News TodayAugust 21, 2025 GLP-1 drugs and vision loss: How significant are the risks? Medical News TodayOzempic reportedly faces $2 billion in lawsuits…
MMedication Read More Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosisAugust 18, 2025 “Today’s decision by the FDA reflects the continued progress in how we understand and treat patients with MASH,…
MMedication Read More Popular Weight Loss Drugs Like Ozempic May Cause Major Muscle Loss Without Boosting Fitness, Study WarnsJuly 22, 2025 A woman injects herself with a GLP-1 receptor antagonist drug. (© Mauricio – stock.adobe.com) GLP-1 drugs like semaglutide…
MMedication Read More Thousands of Ozempic scripts written for under-18s, data showJuly 11, 2025 Under-18s are receiving scripts for the blockbuster semaglutide drug Ozempic despite it not being TGA-approved for children or…